baibr
Lv2
200 积分
2023-06-13 加入
-
Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants
1个月前
已完结
-
Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study
1个月前
已完结
-
A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder
1个月前
已完结
-
Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance
1个月前
已完结
-
Efficacy of risperidone augmentation to antidepressants in the management of suicidality in major depressive disorder: a randomized, double-blind, placebo-controlled pilot study
1个月前
已完结
-
Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study
1个月前
已完结
-
Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study
1个月前
已完结
-
A meta-analysis of the effects of non-invasive brain stimulation on obsessive-compulsive disorder
7个月前
已完结
-
P.324 Augmentation of aripiprazole versus bupropion on specific symptoms of depression in older adults patients: a post-hoc, multi-center, open-label, randomized study
8个月前
已完结
-
Improvements in psychological wellbeing with augmentation vs. switch approaches for treatment-resistant depression in older adults: The optimum study
8个月前
已完结